l 659066 has been researched along with Fasting Hypoglycemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, RC; Kallio-Kujala, IJ; Meierjohann, A; Raekallio, MR; Savontaus, E; Scheinin, M; Spillmann, T; Vainio, OM; Yatkin, E | 1 |
| Bastman, S; Chrusciel, P; Ranta-Panula, V; Ruohonen, ST; Scheinin, M; Streng, T | 1 |
1 trial(s) available for l 659066 and Fasting Hypoglycemia
| Article | Year |
|---|---|
Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.
Topics: Adrenergic alpha-2 Receptor Agonists; Anesthesia, Intravenous; Animals; Blood Glucose; Cross-Over Studies; Dexmedetomidine; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glucagon; Glyburide; Hypnotics and Sedatives; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Quinolizines; Random Allocation; Treatment Outcome | 2018 |
1 other study(ies) available for l 659066 and Fasting Hypoglycemia
| Article | Year |
|---|---|
Potentiation of Glibenclamide Hypoglycaemia in Mice by MK-467, a Peripherally Acting Alpha2-Adrenoceptor Antagonist.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Arterial Pressure; Biomarkers; Blood Glucose; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Glyburide; Heart Rate; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Medetomidine; Mice, Inbred C57BL; Quinolizines; Telemetry; Time Factors | 2015 |